SWAV News

Growth IPOs are finally coming to market, and IPO investors are profiting. ShockWave Medical (SWAV) priced above the range and jumped 79% on its debut, the best first-day pop since Elastic (ESTC) in October (+94%). While it is relatively early stage ($12mm in LTM sales), the company's cardiovascular device has shown advantages over competitors, and its products have...read more

ShockWave Medical, which sells medical systems used in treating cardiovascular disease, raised $97 million by offering 5.7 million shares at $17. The company had originally planned to offer 5.0 million shares at a range of $14 to $16. Additionally, insider Abiomed agreed to invest $10 million in a concurrent private placement. ShockWave Medical plans to list on the Nasdaq under...read more

The February lull is over, and March is kicking off with two growth IPOs targeting almost $200 million in total. Due to the government shutdown and poor 4Q18 returns, this year has seen only 11 IPOs raise $1.2 billion, down from 28 IPOs raising $10.9 billion at this point last year. However, we expect activity to normalize in March and April, helped by strong returns from...read more

ShockWave Medical, which sells medical systems used in treating cardiovascular disease, announced terms for its IPO on Monday. The Santa Clara, CA-based company plans to raise $75 million by offering 5 million shares at a price range of $14 to $16. At the midpoint of the proposed range, ShockWave Medical would command a fully diluted market value of $428 million. ShockWave...read more